Effect of a Soluble Fibre Blend and Medium Chain Triglycerides on Body Composition and Cardiometabolic Risk Factors
Phase 2
Completed
- Conditions
- People Who Are Overweight or Obesity
- Registration Number
- NCT00644098
- Lead Sponsor
- Canadian Center for Functional Medicine
- Brief Summary
The purpose of this study is to investigate whether the addition of capsules containing soluble fibre complex emulsified with medium chain triglycerides and taken before with meals will lead to a significant amount of weight loss, reduced glycemic volatility and diminished cardio metabolic risk factors in overweight and obese individuals when compared to a placebo control.
We believe that those participants taking 3-6 capsules per day of the treatment capsules over a 14 week period will loose a significant amount of weight compared to the placebo group.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 138
Inclusion Criteria
- BMI 27 - 35 kg/m2
Exclusion Criteria
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Primary Outcome Measures
Name Time Method weight loss baseline, biweekly and final visit
- Secondary Outcome Measures
Name Time Method glycemic volatility and cardio metabolic risk factors baseline and final visit
Trial Locations
- Locations (1)
Canadian Center for Functional Medicine
🇨🇦Coquitlam, British Columbia, Canada
Canadian Center for Functional Medicine🇨🇦Coquitlam, British Columbia, Canada